Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-09-12 00:00:00 ET · period of report 2022-09-08 · accession 0001493152-22-025660 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-12 | 2022-09-08+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $17.80 | -7,840 | 0 | -100% | -$139.6K |
| DM | 2022-09-12 | 2022-09-08+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.97 | +7,840 | 3,120 | New | +$15.4K |
| DM | 2022-09-12 | 2022-09-08+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $0.00 | -7,840 | 44.4K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-09 | S | D | 4,544 | $17.50 | 176 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.06 to $18.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-09-09 | M | A | 4,462 | $2.14 | 4,720 | D | — | — | |
| 3 | Common | Common Stock | 2022-09-09 | M | A | 258 | $1.74 | 258 | D | — | — | |
| 4 | Common | Common Stock | 2022-09-08 | S | D | 629 | $18.42 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.40 to $18.505, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-09-08 | S | D | 2,491 | $18.14 | 629 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.39 to $18.385, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2022-09-08 | M | A | 3,120 | $1.74 | 3,120 | D | — | — | |
| 7 | Common | Common Stock | 2022-09-09 | S | D | 176 | $18.54 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.07 to $18.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-09-08 | M | D | 648 | $0.00 | 14,746 | D | $1.74 · — to 2030-09-03 | 648 Common Stock | (F6) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-09-08 | M | D | 2,472 | $0.00 | 34,656 | D | $1.74 · — to 2030-09-03 | 2,472 Common Stock | (F7) A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-09-09 | M | D | 258 | $0.00 | 14,488 | D | $1.74 · — to 2030-09-03 | 258 Common Stock | (F6) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-09-09 | M | D | 4,462 | $0.00 | 44,420 | D | $2.14 · — to 2031-04-02 | 4,462 Common Stock | (F8) A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with shares vesting in 48 substantially equal monthly installments. |